Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 101 articles: HTML format Text format

Single Articles

November 2018
1. LORIMIER G, Seegers V, Coudert M, Dupoiron D, et al
   Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study.
   Eur J Surg Oncol. 2018;44:1824-1831.
   PubMed     Text format     Abstract available
   
   
   
2. MONTRONI I, Ugolini G, Saur NM, Spinelli A, et al
   Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Comm
   Eur J Surg Oncol. 2018;44:1685-1702.
   PubMed     Text format     Abstract available
   
   
   October 2018
3. KLAVER CEL, Wasmann KATGM, Verstegen M, van der Bilt JDW, et al
   Postoperative abdominal infections after resection of T4 colon cancer increase the risk of intra-abdominal recurrence.
   Eur J Surg Oncol. 2018 Oct 18. pii: S0748-7983(18)31435.
   PubMed     Text format     Abstract available
   
   
   
4. SENORE C, Giovo I, Ribaldone DG, Ciancio A, et al
   Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators.
   Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31428.
   PubMed     Text format     Abstract available
   
   
   
5. STERPETTI AV
   "A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al.
   Eur J Surg Oncol. 2018 Oct 11. pii: S0748-7983(18)31444.
   PubMed     Text format    
   
   
   
6. HANGAARD HANSEN C, Gogenur M, Tvilling Madsen M, Gogenur I, et al
   The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: A systematic review.
   Eur J Surg Oncol. 2018;44:1479-1485.
   PubMed     Text format     Abstract available
   
   
   
7. MERTZ-PETERSEN M, Piper TB, Kleif J, Ferm L, et al
   Triage for selection to colonoscopy?
   Eur J Surg Oncol. 2018;44:1539-1541.
   PubMed     Text format     Abstract available
   
   
   
8. PEDERSEN TB, Gocht-Jensen P, Klein MF
   30-day and long-term outcome following salvage surgery for squamous cell carcinoma of the anus.
   Eur J Surg Oncol. 2018;44:1518-1521.
   PubMed     Text format     Abstract available
   
   
   
9. SCHMIDT T, Nienhuser H, Kuna C, Klose J, et al
   Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
   Eur J Surg Oncol. 2018;44:1610-1618.
   PubMed     Text format     Abstract available
   
   
   
10. HUBERT C, Lucidi V, Weerts J, Dili A, et al
    Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:1532-1538.
    PubMed     Text format     Abstract available
    
    
    
11. HAGEMANS JAW, Rothbarth J, Kirkels WJ, Boormans JL, et al
    Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Eur J Surg Oncol. 2018;44:1548-1554.
    PubMed     Text format     Abstract available
    
    
    
12. BOLMSTRAND B, Nilsson PJ, Holm T, Buchli C, et al
    Patterns of complications following urinary tract reconstruction after multivisceral surgery in colorectal and anal cancer.
    Eur J Surg Oncol. 2018;44:1513-1517.
    PubMed     Text format     Abstract available
    
    
    
13. OLTHOF PB, Schnitzbauer AA, Schadde E
    The HPB controversy of the decade: 2007-2017 - Ten years of ALPPS.
    Eur J Surg Oncol. 2018;44:1624-1627.
    PubMed     Text format     Abstract available
    
    
    September 2018
14. SOUWER ETD, Bastiaannet E, de Bruijn S, Breugom AJ, et al
    Comprehensive multidisciplinary care program for elderly colorectal cancer patients: "From prehabilitation to independence".
    Eur J Surg Oncol. 2018 Sep 8. pii: S0748-7983(18)31304.
    PubMed     Text format     Abstract available
    
    
    
15. LI JD, Xu XF, Yu JJ, Yang T, et al
    Is obesity a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery?
    Eur J Surg Oncol. 2018 Sep 6. pii: S0748-7983(18)31294.
    PubMed     Text format    
    
    
    
16. POELEMEIJER YQM, Detering R, Wouters MWJM
    Reply to "Is obesity a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery?"
    Eur J Surg Oncol. 2018 Sep 6. pii: S0748-7983(18)31293.
    PubMed     Text format    
    
    
    
17. LIBERALE G, Bohlok A, Bormans A, Bouazza F, et al
    Indocyanine green fluorescence imaging for sentinel lymph node detection in colorectal cancer: A systematic review.
    Eur J Surg Oncol. 2018;44:1301-1306.
    PubMed     Text format     Abstract available
    
    
    
18. BREUGOM AJ, Bastiaannet E, Boelens PG, Van Eycken E, et al
    Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.
    Eur J Surg Oncol. 2018;44:1338-1343.
    PubMed     Text format     Abstract available
    
    
    
19. VAN DER HEIJDEN JAG, Thomas G, Caers F, van Dijk WA, et al
    What you should know about the low anterior resection syndrome - Clinical recommendations from a patient perspective.
    Eur J Surg Oncol. 2018;44:1331-1337.
    PubMed     Text format     Abstract available
    
    
    August 2018
20. BREUGOM AJ, Bastiaannet E, Dekker JWT, Wouters MWJM, et al
    Decrease in 30-day and one-year mortality over time in patients aged >/=75 years with stage I-III colon cancer: A population-based study.
    Eur J Surg Oncol. 2018 Aug 29. pii: S0748-7983(18)31284.
    PubMed     Text format     Abstract available
    
    
    
21. WESTBERG K, Martling A
    Reply to: Management of locally recurrent rectal cancer.
    Eur J Surg Oncol. 2018;44:1282.
    PubMed     Text format    
    
    
    
22. HUREIBI K
    Management of locally recurrent rectal cancer.
    Eur J Surg Oncol. 2018;44:1281.
    PubMed     Text format    
    
    
    
23. WU J, Wang F, Liu X, Zhang T, et al
    Correlation of IDH1 and B7H3 expression with prognosis of CRC patients.
    Eur J Surg Oncol. 2018;44:1254-1260.
    PubMed     Text format     Abstract available
    
    
    
24. VAN HEINSBERGEN M, Janssen-Heijnen ML, Leijtens JW, Slooter GD, et al
    Bowel dysfunction after sigmoid resection underestimated: Multicentre study on quality of life after surgery for carcinoma of the rectum and sigmoid.
    Eur J Surg Oncol. 2018;44:1261-1267.
    PubMed     Text format     Abstract available
    
    
    
25. CHINO A, Konishi T, Ogura A, Kawachi H, et al
    Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy.
    Eur J Surg Oncol. 2018;44:1247-1253.
    PubMed     Text format     Abstract available
    
    
    
26. MARIATHASAN AB, Boye K, Giercksky KE, Brennhovd B, et al
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.
    Eur J Surg Oncol. 2018;44:1226-1232.
    PubMed     Text format     Abstract available
    
    
    
27. BLOK RD, Stam R, Westerduin E, Borstlap WAA, et al
    Impact of an institutional change from routine to highly selective diversion of a low anastomosis after TME for rectal cancer.
    Eur J Surg Oncol. 2018;44:1220-1225.
    PubMed     Text format     Abstract available
    
    
    July 2018
28. OMMUNDSEN N, Nesbakken A, Wyller TB, Skovlund E, et al
    Post-discharge complications in frail older patients after surgery for colorectal cancer.
    Eur J Surg Oncol. 2018 Jul 7. pii: S0748-7983(18)31168.
    PubMed     Text format     Abstract available
    
    
    
29. MEGE D, Manceau G, Beyer-Berjot L, Bridoux V, et al
    Surgical management of obstructive right-sided colon cancer at a national level results of a multicenter study of the French Surgical Association in 776 patients.
    Eur J Surg Oncol. 2018 Jul 6. pii: S0748-7983(18)31171.
    PubMed     Text format     Abstract available
    
    
    
30. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Text format     Abstract available
    
    
    
31. SUGARBAKER PH
    The hepatic bridge.
    Eur J Surg Oncol. 2018;44:1083-1086.
    PubMed     Text format     Abstract available
    
    
    
32. ROMBOUTS AJM, Hugen N, Verhoeven RHA, Elferink MAG, et al
    Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
    Eur J Surg Oncol. 2018;44:1018-1024.
    PubMed     Text format     Abstract available
    
    
    
33. TRENTI L, Galvez A, Biondo S, Solis A, et al
    Quality of life and anterior resection syndrome after surgery for mid to low rectal cancer: A cross-sectional study.
    Eur J Surg Oncol. 2018;44:1031-1039.
    PubMed     Text format     Abstract available
    
    
    
34. HOENDERVANGERS S, Couwenberg AM, Intven MPW, van Grevenstein WMU, et al
    Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Eur J Surg Oncol. 2018;44:1013-1017.
    PubMed     Text format     Abstract available
    
    
    
35. BERARDI G, De Man M, Laurent S, Smeets P, et al
    Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:1069-1077.
    PubMed     Text format     Abstract available
    
    
    
36. ENBLAD M, Graf W, Birgisson H
    Risk factors for appendiceal and colorectal peritoneal metastases.
    Eur J Surg Oncol. 2018;44:997-1005.
    PubMed     Text format     Abstract available
    
    
    
37. NOWACKI M, Alyami M, Villeneuve L, Mercier F, et al
    Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Eur J Surg Oncol. 2018;44:991-996.
    PubMed     Text format     Abstract available
    
    
    
38. TUFO A, Dunne DFJ, Manu N, Joshi H, et al
    Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.
    Eur J Surg Oncol. 2018;44:1040-1047.
    PubMed     Text format     Abstract available
    
    
    June 2018
39. HARJI DP, Vallance A, Selgimann J, Bach S, et al
    A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumour.
    Eur J Surg Oncol. 2018 Jun 23. pii: S0748-7983(18)31134.
    PubMed     Text format     Abstract available
    
    
    
40. DE NEREE TOT BABBERICH MPM, Detering R, Dekker JWT, Elferink MA, et al
    Achievements in colorectal cancer care during 8 years of auditing in The Netherlands.
    Eur J Surg Oncol. 2018 Jun 8. pii: S0748-7983(18)31117.
    PubMed     Text format     Abstract available
    
    
    
41. QUINTANA JM, Anton-Ladisla A, Gonzalez N, Lazaro S, et al
    Outcomes of open versus laparoscopic surgery in patients with colon cancer.
    Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31110.
    PubMed     Text format     Abstract available
    
    
    
42. VAN VUGT JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, Vrijland WW, et al
    Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer.
    Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31109.
    PubMed     Text format     Abstract available
    
    
    
43. POELEMEIJER YQM, Lijftogt N, Detering R, Fiocco M, et al
    Obesity as a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery: A population-based study (2009-2016).
    Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31104.
    PubMed     Text format     Abstract available
    
    
    
44. HAMMOUDI N, Eveno C, Lambert J, Maillet M, et al
    Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.
    Eur J Surg Oncol. 2018;44:799-804.
    PubMed     Text format     Abstract available
    
    
    
45. WANG K, Xu D, Yan XL, Poston G, et al
    The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
    Eur J Surg Oncol. 2018;44:771-777.
    PubMed     Text format     Abstract available
    
    
    
46. LO DICO R, Tijeras-Raballand A, Bonnin P, Launay JM, et al
    Hepatectomy increases metastatic graft and growth in an immunocompetent murine model of peritoneal metastases.
    Eur J Surg Oncol. 2018;44:784-791.
    PubMed     Text format     Abstract available
    
    
    
47. SUGARBAKER PH
    Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment.
    Eur J Surg Oncol. 2018;44:805-809.
    PubMed     Text format     Abstract available
    
    
    May 2018
48. VALLANCE AE, van der Meulen J, Kuryba A, Braun M, et al
    Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival.
    Eur J Surg Oncol. 2018 May 26. pii: S0748-7983(18)31078.
    PubMed     Text format     Abstract available
    
    
    
49. CLOYD JM, Mizuno T, Vauthey JN
    Reply to: Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.
    Eur J Surg Oncol. 2018 May 18. pii: S0748-7983(18)31070.
    PubMed     Text format    
    
    
    
50. TRAUTMANN F, Reissfelder C, Pecqueux M, Weitz J, et al
    Evidence-based quality standards improve prognosis in colon cancer care.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31067.
    PubMed     Text format     Abstract available
    
    
    
51. CRISTOBAL I, Torrejon B, Santos A, Luque M, et al
    Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.
    Eur J Surg Oncol. 2018 May 9. pii: S0748-7983(18)31027.
    PubMed     Text format    
    
    
    
52. MIZUNO T, Cloyd JM, Vicente D, Omichi K, et al
    SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:684-692.
    PubMed     Text format     Abstract available
    
    
    
53. FERNANDEZ JA, Gomez-Ruiz AJ, Olivares V, Ferri B, et al
    Clinical and pathological features of "small" GIST (</=2 cm). What is their prognostic value?
    Eur J Surg Oncol. 2018;44:580-586.
    PubMed     Text format     Abstract available
    
    
    April 2018
54. MINNELLA EM, Carli F
    Prehabilitation and functional recovery for colorectal cancer patients.
    Eur J Surg Oncol. 2018 Apr 30. pii: S0748-7983(18)31022.
    PubMed     Text format     Abstract available
    
    
    
55. DEGIULI M, Arolfo S, Evangelista A, Lorenzon L, et al
    Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the "Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network"(SICO-CCN) multicentre collaborative study.
    Eur J Surg Oncol. 2018 Apr 17. pii: S0748-7983(18)31012.
    PubMed     Text format     Abstract available
    
    
    
56. BROUWER NPM, Stijns RCH, Lemmens VEPP, Nagtegaal ID, et al
    Clinical lymph node staging in colorectal cancer; a flip of the coin?
    Eur J Surg Oncol. 2018 Apr 17. pii: S0748-7983(18)31013.
    PubMed     Text format     Abstract available
    
    
    
57. FALCAO D, Alexandrino H, Caetano Oliveira R, Martins J, et al
    Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
    Eur J Surg Oncol. 2018 Apr 11. pii: S0748-7983(18)30992.
    PubMed     Text format     Abstract available
    
    
    
58. SHIDA D, Ochiai H, Tsukamoto S, Kanemitsu Y, et al
    Long-term outcomes of laparoscopic versus open D3 dissection for stage II/III colon cancer: Results of propensity score analyses.
    Eur J Surg Oncol. 2018 Apr 5. pii: S0748-7983(18)30991.
    PubMed     Text format     Abstract available
    
    
    
59. ITO M, Kobayashi A, Fujita S, Mizusawa J, et al
    Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG02
    Eur J Surg Oncol. 2018;44:463-468.
    PubMed     Text format     Abstract available
    
    
    
60. LORENZON L, Biondi A, Carus T, Dziki A, et al
    Achieving high quality standards in laparoscopic colon resection for cancer: A Delphi consensus-based position paper.
    Eur J Surg Oncol. 2018;44:469-483.
    PubMed     Text format     Abstract available
    
    
    
61. FIGUEIREDO N, Panteleimonitis S, Popeskou S, Cunha JF, et al
    Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Eur J Surg Oncol. 2018;44:484-489.
    PubMed     Text format     Abstract available
    
    
    
62. HUTTNER FJ, Warschkow R, Schmied BM, Diener MK, et al
    Prognostic impact of anastomotic leakage after elective colon resection for cancer - A propensity score matched analysis of 628 patients.
    Eur J Surg Oncol. 2018;44:456-462.
    PubMed     Text format     Abstract available
    
    
    March 2018
63. ZABALETA J, Iida T, Falcoz PE, Salah S, et al
    Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis.
    Eur J Surg Oncol. 2018 Mar 21. pii: S0748-7983(18)30957.
    PubMed     Text format     Abstract available
    
    
    
64. POLOM K, Boger C, Smyth E, Marrelli D, et al
    Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
    Eur J Surg Oncol. 2018 Mar 2. pii: S0748-7983(18)30882.
    PubMed     Text format     Abstract available
    
    
    February 2018
65. CASHIN PH, Mahteme H, Syk I, Frodin JE, et al
    Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases.
    Eur J Surg Oncol. 2018 Feb 21. pii: S0748-7983(18)30672.
    PubMed     Text format     Abstract available
    
    
    
66. SHIM JR, Lee SD, Han SS, Lee SJ, et al
    Prognostic significance of (18)F-FDG PET/CT in patients with colorectal cancer liver metastases after hepatectomy.
    Eur J Surg Oncol. 2018 Feb 6. pii: S0748-7983(18)30292.
    PubMed     Text format     Abstract available
    
    
    
67. FURUKI H, Yamada T, Takahashi G, Iwai T, et al
    Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
    Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30273.
    PubMed     Text format     Abstract available
    
    
    
68. STIJNS RCH, Tromp MR, Hugen N, de Wilt JHW, et al
    Advances in organ preserving strategies in rectal cancer patients.
    Eur J Surg Oncol. 2018;44:209-219.
    PubMed     Text format     Abstract available
    
    
    
69. PEREZ D, Melling N, Biebl M, Reeh M, et al
    Robotic low anterior resection versus transanal total mesorectal excision in rectal cancer: A comparison of 115 cases.
    Eur J Surg Oncol. 2018;44:237-242.
    PubMed     Text format     Abstract available
    
    
    
70. MORALES-SORIANO R, Esteve-Perez N, Segura-Sampedro JJ, Cascales-Campos P, et al
    Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
    Eur J Surg Oncol. 2018;44:228-236.
    PubMed     Text format     Abstract available
    
    
    January 2018
71. OKAMURA R, Hida K, Nishizaki D, Sugihara K, et al
    Proposal of a stage-specific surveillance strategy for colorectal cancer patients: A retrospective analysis of Japanese large cohort.
    Eur J Surg Oncol. 2018 Jan 31. pii: S0748-7983(18)30116.
    PubMed     Text format     Abstract available
    
    
    
72. SHEN Z, Lin Y, Ye Y, Jiang K, et al
    The development and validation of a novel model for predicting surgical complications in colorectal cancer of elderly patients: Results from 1008 cases.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30034.
    PubMed     Text format     Abstract available
    
    
    
73. WESTBERG K, Palmer G, Hjern F, Johansson H, et al
    Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Eur J Surg Oncol. 2018;44:100-107.
    PubMed     Text format     Abstract available
    
    
    
74. SAO JULIAO GP, Habr-Gama A, Vailati BB, Aguilar PB, et al
    Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    Eur J Surg Oncol. 2018;44:93-99.
    PubMed     Text format     Abstract available
    
    
    
75. OMICHI K, Shindoh J, Cloyd JM, Mizuno T, et al
    Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Eur J Surg Oncol. 2018;44:122-129.
    PubMed     Text format     Abstract available
    
    
    
76. STIFT J, Graf A, Schwarz C, Tamandl D, et al
    Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:139-147.
    PubMed     Text format     Abstract available
    
    
    
77. LINTER KAPISINSKA M, Hovorkova E, Zavalova V, Subrt Z, et al
    Distribution of metastases in mesorectum is unpredictable: Metastases do not respect tumor localization even in small non-circumferential rectal cancers.
    Eur J Surg Oncol. 2018;44:87-92.
    PubMed     Text format     Abstract available
    
    
    
78. DUPRE A, Malik HZ, Jones RP, Diaz-Nieto R, et al
    Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:80-86.
    PubMed     Text format     Abstract available
    
    
    
79. SUTTON PA, Jithesh PV, Jones RP, Evans JP, et al
    Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.
    Eur J Surg Oncol. 2018;44:115-121.
    PubMed     Text format     Abstract available
    
    
    
80. JONES HJS, Cunningham C, Nicholson GA, Hompes R, et al
    Outcomes following completion and salvage surgery for early rectal cancer: A systematic review.
    Eur J Surg Oncol. 2018;44:15-23.
    PubMed     Text format     Abstract available
    
    
    
81. HUISKENS J, Olthof PB, van der Stok EP, Bais T, et al
    Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
    Eur J Surg Oncol. 2018;44:108-114.
    PubMed     Text format     Abstract available
    
    
    December 2017
82. DESJARDIN M, Desolneux G, Brouste V, Degrandi O, et al
    Parenchymal sparing surgery for colorectal liver metastases: The need for a common definition.
    Eur J Surg Oncol. 2017;43:2285-2291.
    PubMed     Text format     Abstract available
    
    
    
83. CHAPELLE T, Op de Beeck B, Driessen A, Roeyen G, et al
    Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores.
    Eur J Surg Oncol. 2017;43:2277-2284.
    PubMed     Text format     Abstract available
    
    
    November 2017
84. REHA J, Mukkamalla SKR, Rathore R, Somasundar PS, et al
    Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base.
    Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30966.
    PubMed     Text format     Abstract available
    
    
    
85. VAN EDEN WJ, Kok NFM, Woensdregt K, Huitema ADR, et al
    Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
    Eur J Surg Oncol. 2017 Nov 15. pii: S0748-7983(17)30956.
    PubMed     Text format     Abstract available
    
    
    
86. OFFERMANS T, Vogelaar FJ, Aquarius M, Janssen-Heijnen MLG, et al
    Preoperative segmental localization of colorectal carcinoma: CT colonography vs. optical colonoscopy.
    Eur J Surg Oncol. 2017;43:2105-2111.
    PubMed     Text format     Abstract available
    
    
    
87. YOUNG CJ, Zahid A, Choy I, Thompson JF, et al
    Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
    Eur J Surg Oncol. 2017;43:2163-2169.
    PubMed     Text format     Abstract available
    
    
    
88. SIDDIQUI MRS, Shanmuganandan AP, Rasheed S, Tekkis P, et al
    An audit comparing the reporting of staging MRI scans for rectal cancer with the London Cancer Alliance (LCA) guidelines.
    Eur J Surg Oncol. 2017;43:2093-2104.
    PubMed     Text format     Abstract available
    
    
    
89. GASH KJ, Baser O, Kiran RP
    Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes.
    Eur J Surg Oncol. 2017;43:2052-2059.
    PubMed     Text format     Abstract available
    
    
    
90. HELDENS AFJM, Bongers BC, Lenssen AF, Stassen LPS, et al
    The association between performance parameters of physical fitness and postoperative outcomes in patients undergoing colorectal surgery: An evaluation of care data.
    Eur J Surg Oncol. 2017;43:2084-2092.
    PubMed     Text format     Abstract available
    
    
    
91. LEE SH, Lee JL, Kim CW, Lee HI, et al
    Oncologic significance of para-aortic lymph node and inferior mesenteric lymph node metastasis in sigmoid and rectal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:2076-2083.
    PubMed     Text format     Abstract available
    
    
    
92. PETZ W, Ribero D, Bertani E, Borin S, et al
    Suprapubic approach for robotic complete mesocolic excision in right colectomy: Oncologic safety and short-term outcomes of an original technique.
    Eur J Surg Oncol. 2017;43:2060-2066.
    PubMed     Text format     Abstract available
    
    
    October 2017
93. DUPRE A, Jones RP, Diaz-Nieto R, Fenwick SW, et al
    Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Eur J Surg Oncol. 2017;43:1901-1907.
    PubMed     Text format     Abstract available
    
    
    
94. SUN Y, Xu Z, Lin H, Lu X, et al
    Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Eur J Surg Oncol. 2017;43:1828-1834.
    PubMed     Text format     Abstract available
    
    
    
95. JONKER FHW, Hagemans JAW, Verhoef C, Burger JWA, et al
    The impact of hospital volume on perioperative outcomes of rectal cancer.
    Eur J Surg Oncol. 2017;43:1894-1900.
    PubMed     Text format     Abstract available
    
    
    
96. KVERNENG HULTBERG D, Angenete E, Lydrup ML, Rutegard J, et al
    Nonsteroidal anti-inflammatory drugs and the risk of anastomotic leakage after anterior resection for rectal cancer.
    Eur J Surg Oncol. 2017;43:1908-1914.
    PubMed     Text format     Abstract available
    
    
    
97. SOLON JG, O'Neill M, Chang KH, Deady S, et al
    An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland.
    Eur J Surg Oncol. 2017;43:1924-1931.
    PubMed     Text format     Abstract available
    
    
    September 2017
98. DUWE G, Knitter S, Pesthy S, Beierle AS, et al
    Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection.
    Eur J Surg Oncol. 2017;43:1668-1681.
    PubMed     Text format     Abstract available
    
    
    August 2017
99. BIN TRAIKI TA, Fisher OM, Valle SJ, Parikh RN, et al
    Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis.
    Eur J Surg Oncol. 2017 Aug 31. pii: S0748-7983(17)30639.
    PubMed     Text format     Abstract available
    
    
    
100. CURRIE AC, Brigic A, Thomas-Gibson S, Suzuki N, et al
     A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer.
     Eur J Surg Oncol. 2017 Aug 23. pii: S0748-7983(17)30643.
     PubMed     Text format     Abstract available
     
     
     
101. POSTON G, Adam R, Xu J, Byrne B, et al
     The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.
     Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30605.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: